Document Detail


Effects of nortriptyline and paroxetine on QT variability in patients with panic disorder.
MedLine Citation:
PMID:  10875054     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
This study investigated beat-to-beat QT variability in patients with panic disorder before and after treatment with nortriptyline (n = 13) and paroxetine (n = 16), using an automated algorithm to compute QT intervals. An increase in QT variability appears to be associated with symptomatic patients with dilated cardiomyopathy and also with an increased risk for sudden cardiac death. QTvi (QT variability index: a log ratio of QT variance normalized for mean QT over heart rate variability normalized for mean heart rate) was significantly higher in supine posture in patients with panic disorder treated with nortriptyline (P = 0.006) but not paroxetine. Thus paroxetine may be a better drug of choice especially in patients with coexisting cardiac disease. These findings are important especially in view of the recent reports of increased risk for cardiovascular mortality and sudden death in patients with anxiety and depression. QTvi can be a valuable noninvasive measure of temporal repolarization lability, especially to study the side effects of medications which affect cardiac autonomic function.
Authors:
V K Yeragani; R Pohl; V C Jampala; R Balon; C Ramesh; K Srinivasan
Related Documents :
19954504 - Ventricular late potential in patients with apparently normal electrocardiogram; predic...
16550374 - Takotsubo cardiomyopathy (acute left ventricular apical ballooning syndrome) occurring ...
19824814 - The effect of oral methadone on the qtc interval in advanced cancer patients: a prospec...
11982864 - Longitudinal estimation of signal-averaged electrocardiograms in patients with kawasaki...
20351674 - Hemodynamic patterns of chronic cerebrospinal venous insufficiency in multiple sclerosi...
4019784 - Identification of the lymphokine soluble immune response suppressor in urine of nephrot...
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Depression and anxiety     Volume:  11     ISSN:  1091-4269     ISO Abbreviation:  Depress Anxiety     Publication Date:  2000  
Date Detail:
Created Date:  2000-11-15     Completed Date:  2000-11-15     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  9708816     Medline TA:  Depress Anxiety     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  126-30     Citation Subset:  IM    
Affiliation:
Department of Psychiatry, Wayne State University School of Medicine, Detroit, Michigan, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Antidepressive Agents, Tricyclic / adverse effects*,  therapeutic use
Death, Sudden, Cardiac / etiology
Electrocardiography / drug effects*
Female
Heart Rate / drug effects
Humans
Long QT Syndrome / chemically induced*,  diagnosis
Male
Nortriptyline / adverse effects*,  therapeutic use
Panic Disorder / drug therapy*,  psychology
Paroxetine / adverse effects*,  therapeutic use
Risk Factors
Serotonin Uptake Inhibitors / adverse effects*,  therapeutic use
Grant Support
ID/Acronym/Agency:
R01 MH50752/MH/NIMH NIH HHS
Chemical
Reg. No./Substance:
0/Antidepressive Agents, Tricyclic; 0/Serotonin Uptake Inhibitors; 61869-08-7/Paroxetine; 72-69-5/Nortriptyline

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Over-representation of Myers Briggs Type Indicator introversion in social phobia patients.
Next Document:  Anxiety contributes to suicidality in depressed adolescents.